The Tyr113His mEH polymorphism has been extensively investigated for its potential involvement in various types of cancers, such as colorectal cancer [19], lung and upper digestive tract cancer [20], esophageal carcinoma [21], and hepatocellular carcinoma [22]. This evidence concerns the gene EPHX1 and colorectal cancer.